BCI
LAB icon

Brinker Capital Investments’s Standard BioTools LAB Stock Holding History

Brinker Capital Investments’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1
Closed – – 572
2016
Q3 		$0 Buy
+1
New +$9 ﹤0.01% 565
2016
Q1 		– Sell
-2
Closed – – 569
2015
Q4 		$0 Buy
+2
New +$20 ﹤0.01% 665

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Brinker Capital Investments's LAB Position: Q4 2016 in Review

Brinker Capital Investments sold out of Standard BioTools (LAB) in Q4 2016, closing a stake of 1 share.

Brinker Capital Investments first reported a position in LAB in Q4 2015 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 83 funds tracked by Wall St. Rank hold LAB as of Q4 2016.

  • Brinker Capital Investments reported no remaining Standard BioTools position as of Q4 2016 after selling out during the quarter.
  • Brinker Capital Investments sold 1 Standard BioTools share in Q4 2016.
  • Brinker Capital Investments first reported a position in Standard BioTools in Q4 2015 and held it in 2 quarters.
  • Brinker Capital Investments's Standard BioTools position peaked at $0 in Q3 2016.
  • 83 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2016.

Based on Brinker Capital Investments's 13F filing for Q4 2016, filed 8 Feb 2017.